Literature DB >> 10392850

Differential distribution of urocortin- and corticotropin-releasing factor-like immunoreactivities in the rat brain.

S M Morin1, N Ling, X J Liu, S D Kahl, D R Gehlert.   

Abstract

Urocortin, a novel 40 amino acid neuropeptide, is a member of the corticotropin-releasing factor family. With 45% homology to corticotropin-releasing factor, urocortin binds with similar affinity to the corticotropin-releasing factor- and corticotropin-releasing factor-2 receptors and may play a role in modulating many of the same systems as corticotropin-releasing factor. To assess whether urocortin and corticotropin-releasing factor are localized in the same regions of the brain, we compared the distribution of urocortin- and corticotropin-releasing factor-like immunoreactivities in the rat central nervous system. Polyclonal antibodies to rat corticotropin-releasing factor and rat urocortin were generated and utilized to map the distribution of corticotropin-releasing factor- and urocortin-like immunoreactivities throughout the rat forebrain and brainstem. Characterization of the antibodies by radioimmunoassay showed no cross-reactivity with related peptides. Male Sprague-Dawley rats were treated with colchicine for 18-24 h. Following colchicine treatment, the rats were perfused with paraformaldehyde-lysine-periodate fixative and their brains removed. Serial coronal sections were taken throughout the rat brain and processed for either corticotropin-releasing factor- or urocortin-like immunoreactivity. Urocortin-like immunoreactivity shows a discrete localization within several regions including the supraoptic nucleus, the median eminence, Edinger-Westphal nucleus and the sphenoid nucleus. This is in contrast to the more abundant corticotropin-releasing factor-like immunoreactivity. Regions containing high levels of corticotropin-releasing factor immunoreactivity include the lateral septum, paraventricular nucleus of the hypothalamus, median eminence and locus coeruleus. There are a few regions that contain both urocortin-immunoreactive and corticotropin-releasing factor-immunoreactive cells, such as the supraoptic nucleus and the hippocampus. Therefore, urocortin and corticotropin-releasing factor appear to have different distribution patterns which may be indicative of their respective physiological functions.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10392850     DOI: 10.1016/s0306-4522(98)00732-5

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  42 in total

1.  Corticotropin-releasing factor and urocortin I activate CREB through functionally selective Gβγ signaling in hippocampal pyramidal neurons.

Authors:  Christopher M Stern; John Meitzen; Paul G Mermelstein
Journal:  Eur J Neurosci       Date:  2011-08-08       Impact factor: 3.386

2.  Distribution of corticotropin-releasing factor and urocortin 1 in the vole brain.

Authors:  Miranda M Lim; Natalia O Tsivkovskaia; Yaohui Bai; Larry J Young; Andrey E Ryabinin
Journal:  Brain Behav Evol       Date:  2006-06-30       Impact factor: 1.808

Review 3.  Preclinical evidence implicating corticotropin-releasing factor signaling in ethanol consumption and neuroadaptation.

Authors:  T J Phillips; C Reed; R Pastor
Journal:  Genes Brain Behav       Date:  2015-01       Impact factor: 3.449

Review 4.  Urocortins: CRF's siblings and their potential role in anxiety, depression and alcohol drinking behavior.

Authors:  Andrey E Ryabinin; Michael M Tsoory; Tamas Kozicz; Todd E Thiele; Adi Neufeld-Cohen; Alon Chen; Emily G Lowery-Gionta; William J Giardino; Simranjit Kaur
Journal:  Alcohol       Date:  2012-03-22       Impact factor: 2.405

5.  Comparison of CRF-immunoreactive neurons distribution in mouse and rat brains and selective induction of Fos in rat hypothalamic CRF neurons by abdominal surgery.

Authors:  Lixin Wang; Miriam Goebel-Stengel; Andreas Stengel; S Vincent Wu; Gordon Ohning; Yvette Taché
Journal:  Brain Res       Date:  2011-07-23       Impact factor: 3.252

6.  Anxiogenic and aversive effects of corticotropin-releasing factor (CRF) in the bed nucleus of the stria terminalis in the rat: role of CRF receptor subtypes.

Authors:  Lacey L Sahuque; Erika F Kullberg; Andrew J Mcgeehan; Jennifer R Kinder; Megan P Hicks; Mary G Blanton; Patricia H Janak; M Foster Olive
Journal:  Psychopharmacology (Berl)       Date:  2006-03-28       Impact factor: 4.530

7.  Urocortin, but not urocortin II, protects cultured hippocampal neurons from oxidative and excitotoxic cell death via corticotropin-releasing hormone receptor type I.

Authors:  Ward A Pedersen; Ruiqian Wan; Peisu Zhang; Mark P Mattson
Journal:  J Neurosci       Date:  2002-01-15       Impact factor: 6.167

Review 8.  CRF1 receptor signaling pathways are involved in stress-related alterations of colonic function and viscerosensitivity: implications for irritable bowel syndrome.

Authors:  Y Taché; V Martinez; L Wang; M Million
Journal:  Br J Pharmacol       Date:  2004-04       Impact factor: 8.739

9.  Corticotropin releasing factor receptor antagonists: potential future therapy in gastroenterology?

Authors:  Y Taché
Journal:  Gut       Date:  2004-07       Impact factor: 23.059

Review 10.  The central corticotropin releasing factor system during development and adulthood.

Authors:  Aniko Korosi; Tallie Z Baram
Journal:  Eur J Pharmacol       Date:  2008-01-19       Impact factor: 4.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.